|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-4-22
|
|
pubmed:abstractText |
Suicidal behavior has been associated with reduced central serotonergic function. Because selective serotonin reuptake inhibitors (SSRIs) enhance serotonergic function, the authors studied the efficacy of an SSRI, paroxetine, in the prevention of recurrent suicidal behavior.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
155
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
543-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9546002-Adult,
pubmed-meshheading:9546002-Anger,
pubmed-meshheading:9546002-Depression,
pubmed-meshheading:9546002-Double-Blind Method,
pubmed-meshheading:9546002-Female,
pubmed-meshheading:9546002-Humans,
pubmed-meshheading:9546002-Male,
pubmed-meshheading:9546002-Mental Disorders,
pubmed-meshheading:9546002-Paroxetine,
pubmed-meshheading:9546002-Patient Dropouts,
pubmed-meshheading:9546002-Personality Disorders,
pubmed-meshheading:9546002-Placebos,
pubmed-meshheading:9546002-Recurrence,
pubmed-meshheading:9546002-Serotonin Uptake Inhibitors,
pubmed-meshheading:9546002-Suicide,
pubmed-meshheading:9546002-Suicide, Attempted,
pubmed-meshheading:9546002-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression.
|
|
pubmed:affiliation |
Department of Psychiatry, Leiden University, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
